1Rankin SC, Taylor H, Cook GJ, et al. Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. Chin Radiol,1998, 53(9) :659-655.
2Kole AC,Plukker JT, Nieweg OE, et al. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer, 1998,78 (4) :521-527.
3Kneist W,Schreckenberger M, Bartenstein P, et al. Positron emission tomography for staging of esophageal cancer: does it lead to a different therapeutic approach? World J Surg ,2003,27 ( 10 ): 1105-1112.
4McAteer D,Wallis F,Couper G, et al. Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma. Br J Radiol, 1999,72 ( 858 ) :525-529.
5Kato H, Kuwano H, Nakajima M, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma . Cancer, 2002, 15,94 ( 4 ): 921 -928.
6Himeno S, Yasuda S, Shimada H, et al. Evaluation of esophageal cancer by positron emission tomography. Jpn J Clin Oncol, 2002,32 (9):340-346.
7Menzel Ch,Dobert N,Rieker O,et al. 18F-Deoxyglucose PET for the staging of oesophageal cancer: influence of histopathological subtype and tumour grading. Nuklearmedizin ,2003,42( 3 ) :90-93.
8Kato H,Takita J,Miyazaki T, et al. Correlation of 18-F-fluorodeoxyglucose(FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma . Anticancer Res,2003,23 (4) :3263-3272.
9Stahl A, Ott K, Weber WA, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. EurJ Nucl Med Mol Imaging,2003,30(2):288-295.
10Kawamura T, Kusakabe T, Sugino T, et al. Expression of glucose transporter-1 in human gastric carcinoma Association with tumour aggressiveness, metastasis, and patient survival. Cancer, 2001,92(3) :634-641.
3Brady Z,Taylor M L, Haynes M,et al. The clinical application of PET/CT: a contemporary review[J]. Australas Phys Eng Sci Med,2008,31(2) :90-109.
4Flanagan F L,Dehdashti F,Siegel B A,et al. Staging of esophageal cancer with ^18F-fluorodeoxyglucose positron emission tomography[J]. AJR, 1997,168 (2) : 417-424.
5Kim K, Park S J, Kim B T, et al. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography[J]. Ann Thorac Surg, 2001,71(1) : 290-294.
6Kato H, Kuwano H, Nakajima M, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma[J]. Cancer, 2002,94 (4) : 921-928.
7Watanabe H,Kato H,Tachimori Y.Significance of extended systemic lymph node dissection for thoracic esophageal carcinoma in Japan.Recent Results Cancer Res,2000,155:123-133.
8Udagawa H,Akiyama H.Surgical treatment of esophageal cancer:Tokyo experience of the three-field technique.Dis Esophagus,2001,14 (2):110-114.
9Kakegawa T.The history of surgical treatment for esophageal carcinoma in the 20th century in Japan.Nippon Geka Gakkai Zasshi,2000,101(12):847-854.
10Igaki H,Kato H,Tachimori Y,et al.Cervical lymph node metastasis in patients with submucosal carcinoma of the thoracic esophagus.J Surg Oncol,2000,75 (1):37-41.
